This is a non-core endpoint: only basic statistics are computed.
Injury of blood vessels at shoulder and upper arm level
ST19_INJURY_BLOOD_VESSE_SHOUL_UPPER_ARM_LEVEL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
64 |
4. Check minimum number of eventsNone |
64 |
5. Include endpointsNone |
64 |
6. Filter based on genotype QC (FinnGen only) |
64 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_SHOUL_UPPER_ARM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S4
- Name in latin
- Laesiones vasorum sanguineorum regionis deltoideae/brachii
Similar endpoints
↥List of similar endpoints to
Injury of blood vessels at shoulder and upper arm level
based on the number of shared cases.
Similar with more cases:
- Injuries to the shoulder and upper arm
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 64 | 26 | 38 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 59.05 | 57.68 | 59.99 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 61
- Matched controls
- 608
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S45.0
ICD-10 Finland
Injury of axillary artery
+∞
22.2
20
*
S45.9
ICD-10 Finland
Injury of unspecified blood vessel at shoulder and upper arm level
+∞
21.0
19
*
S45.1
ICD-10 Finland
Injury of brachial artery
+∞
16.4
15
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
44.8
16.0
19
6
S42.2
ICD-10 Finland
Fracture of upper end of humerus
131.7
10.8
11
*
S43.0
ICD-10 Finland
Dislocation of shoulder joint
+∞
10.7
10
*
X58
ICD-10 Finland
Exposure to other specified factors
8.4
9.8
23
41
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
24.4
8.9
12
6
NB6AA
NOMESCO Finland
Humerus X-ray examination
90.7
7.6
8
*
NBJ62
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus
+∞
7.4
7
*
X59
ICD-10 Finland
Exposure to unspecified factor
5.2
6.7
22
59
NBH10
NOMESCO Finland
Reduction of dislocation of humeroscapular joint, closed
+∞
6.3
6
*
PH1CD
NOMESCO Finland
Very extensive CT angiography of upper extremity and neck veins and superior vena cava
+∞
6.3
6
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.9
6.2
38
180
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
13
23
6.84
7.40
5.4
9.1
25.3
24.1
mmol/l
0.85
13
23
28
115
3.55
5.64
4.2
2.1
—
—
—
0
0
15
46
3.95
4.52
6.0
4.2
5.6
5.6
kpa
0.01
15
46
43
252
3.15
4.51
11.3
6.8
1.2
1.2
mmol/l
0.16
36
206
18
70
3.19
3.78
4.9
6.9
11.3
11.1
kpa
0.08
18
65
18
70
3.19
3.78
4.9
6.8
5.1
4.9
kpa
0.52
18
65
6
8
8.12
3.12
3.7
1.6
90.2
90.1
%
—
6
8
35
211
2.45
3.07
2.1
1.9
94.6
92.4
pmol/l
0.09
19
108
38
240
2.44
2.98
5.7
4.3
—
—
—
0
0
10
31
3.64
2.91
2.5
2.6
1.1
1.2
%
—
10
31
9
27
3.70
2.50
2.4
1.7
—
—
—
0
0
9
27
3.70
2.50
2.1
4.8
70.4
53.2
%
—
9
27
45
322
2.34
2.46
6.7
5.0
6.8
6.8
mmol/l
0.04
45
304
5
8
6.66
2.41
1.2
1.0
—
—
—
0
0
6
16
4.02
1.98
1.3
1.3
—
—
—
0
0
7
23
3.29
1.86
1.4
1.5
8.5
8.2
g/l
—
7
15
7
23
3.29
1.86
1.4
1.5
—
—
—
0
0
6
18
3.56
1.79
1.7
1.7
36.6
36.5
g/l
—
6
13
26
165
1.97
1.78
4.8
4.1
80.2
11.6
mg/mmol
0.68
18
102
5
13
4.07
1.75
4.6
2.0
—
—
—
0
0
21
125
2.01
1.71
1.9
1.5
20.9
19.1
nmol/l
0.15
16
100
40
297
1.92
1.70
7.6
10.3
5.0
4.5
e9/l
0.61
34
257
29
201
1.81
1.47
5.3
3.1
—
—
—
0
0
16
93
1.96
1.37
2.2
1.8
—
—
—
0
0
7
33
2.26
1.09
1.9
1.2
—
—
—
0
0
11
61
1.97
1.06
2.6
1.5
—
—
—
0
0
12
72
1.82
0.93
1.2
1.3
5.8
14.4
u/ml
—
6
20
6
31
2.03
0.87
5.5
3.7
1.0
2.5
mmol/l
—
6
22
11
66
1.81
0.85
6.1
3.2
—
—
—
0
0
15
100
1.65
0.82
1.1
1.2
2.8
1.0
u/ml
—
5
27
13
84
1.69
0.79
4.6
2.9
2.1
0.9
e6/l
—
6
53
9
55
1.74
0.78
14.1
9.8
—
—
—
0
0
13
85
1.66
0.76
5.1
3.0
3.0
2.9
e6/l
—
6
55
7
41
1.79
0.72
2.4
1.6
—
—
—
0
0
21
158
1.49
0.69
5.8
2.8
0.1
0.5
e6/l
1.80
15
123
53
480
1.61
0.67
4.1
4.2
1.4
1.3
mmol/l
0.33
45
430
10
64
1.67
0.63
2.8
1.6
—
—
—
0
0
9
64
1.47
0.54
1.4
1.4
—
—
—
0
0
54
500
1.51
0.50
4.4
4.6
4.3
4.5
mmol/l
0.62
48
455
54
500
1.51
0.50
4.4
4.5
1.3
1.4
mmol/l
0.65
47
450
5
31
1.66
0.44
1.6
2.0
—
—
—
0
0
18
146
1.32
0.38
3.2
3.0
1.3
0.7
ug/l
0.53
13
97
28
242
1.28
0.37
6.0
5.4
4.7
3.5
ug/l
0.23
23
214
23
194
1.29
0.37
4.0
4.6
20.6
21.5
%
0.08
13
100
54
512
1.35
0.30
36.6
15.7
26.6
24.9
mg/l
0.17
47
418
31
283
1.19
0.22
3.3
2.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
54
518
1.27
0.21
5.5
5.3
2.6
2.7
mmol/l
0.42
48
466
23
211
1.14
0.14
5.3
4.6
—
—
—
0
0
5
48
1.05
0.09
5.4
5.7
26.1
24.8
mmol/l
—
5
43
6
54
1.12
0.09
1.3
1.4
—
—
—
0
0
6
70
0.84
0.08
1.5
5.7
4.1
71.4
ug/l
—
6
59
48
489
0.93
0.04
8.0
6.6
40.6
41.4
mmol/mol
0.22
41
449
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
55
546
1.05
0.00
36.1
18.2
103.2
82.0
umol/l
1.02
55
546
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_BLOOD_VESSE_SHOUL_UPPER_ARM_LEVEL – Injury of blood vessels at shoulder and upper arm level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).